Article
Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.
British journal of haematology - 1 Jul 1999
Dumontet C, Fabianowska-Majewska K, Mantincic D, Callet Bauchu E, Tigaud I, Gandhi V, Lepoivre M, Peters G J, Rolland M O, Wyczechowska D, Fang X, Gazzo S, Voorn D A, Vanier-Viornery A, MacKey J
Abstract excerpt
Resistant variants of the human leukaemic line K562 were developed using selection with the deoxynucleoside analogues cytosine arabinoside, 2-chlorodeoxyadenosine, fludarabine and gemcitabine. The resistant lines displayed a high degree of cross resistance to all deoxynucleoside analogues, with little or no cross resistance to other agents. There was a profound accumulation defect of all nucleoside analogues in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
